Skip to main content
Frontiers in Immunology logoLink to Frontiers in Immunology
. 2023 Dec 18;14:1352525. doi: 10.3389/fimmu.2023.1352525

Corrigendum: A TNFR2-specific TNF fusion protein with improved in vivo activity

Juan Gamboa Vargas 1,2,, Jennifer Wagner 3,, Haroon Shaikh 1,2, Isabell Lang 3, Juliane Medler 3, Mohamed Anany 3,4, Tim Steinfatt 1, Josefina Peña Mosca 1,2, Stephanie Haack 1, Julia Dahlhoff 1, Maike Büttner-Herold 5, Carolin Graf 1, Estibaliz Arellano Viera 1, Hermann Einsele 1, Harald Wajant 3,*,, Andreas Beilhack 1,2,
PMCID: PMC10758134  PMID: 38164131

Incorrect Affiliation

In the published article, there was an error in affiliation “4”. Instead of “Department of Microbial Biotechnology, Institute of Biotechnology, Giza, Egypt”, it should be “Department of Microbial Biotechnology, Institute of Biotechnology, National Research Center, Giza, Egypt”.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.


Articles from Frontiers in Immunology are provided here courtesy of Frontiers Media SA

RESOURCES